LifeMD Inc (LFMD)

Currency in USD
3.46
+0.26(+8.13%)
Closed·
3.33-0.13(-3.76%)
·
Trading near 52-week Low
LFMD is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
3.183.54
52 wk Range
3.1815.84
Key Statistics
Prev. Close
3.2
Open
3.2
Day's Range
3.18-3.54
52 wk Range
3.18-15.84
Volume
1.5M
Average Volume (3m)
1.21M
1-Year Change
-30.46%
Book Value / Share
0.03
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
LFMD Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
9.25
Upside
+167.34%
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins

LifeMD Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

LifeMD Company Profile

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company operates through two operating segments: Telehealth and WorkSimpli. The company offers telehealth platform comprising RexMD, a men’s telehealth brand that provides access to virtual medical treatment for a variety of men’s health needs, including erectile dysfunction, premature ejaculation, and hair loss; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; and Cleared which provides personalized treatments for allergy, asthma and immunology. It also provides LifeMD PC, a virtual primary care and telehealth service which is a provider for their primary care, urgent care, and chronic care needs; and offers virtual medical care, including on-demand consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, integration with in-home tools, and more. In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses. Further, it offers GLP-1 for weight management and in-home health monitoring devices. It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York.

LifeMD Inc Earnings Call Summary for Q3/2025

  • LifeMD reported Q3 2025 EPS of -$0.10 (missing -$0.04 forecast) with revenue of $60.2M (up 13% YoY but below $62.13M forecast); stock rose 2.16% in regular trading and 8.86% premarket
  • Telehealth segment grew 18% YoY to $47.3M with 30% rise in telehealth adjusted EBITDA, demonstrating improved operational efficiency despite gross margin declining 290 basis points to 88%
  • Company maintains strong financial position with $23.8M cash and no debt; strategic focus on expanding telehealth and pharmacy services, including partnerships with Novo Nordisk and Eli Lilly
  • CEO Justin Schreiber emphasized 'playing the long game in the GLP-1 space,' positioning LifeMD as a comprehensive virtual care destination amid competition in the compounded GLP-1 medication market
  • Q4 2025 guidance projects revenue of $45-46M and adjusted EBITDA of $3-4M; full-year 2025 forecast of $192-193M revenue with adjusted EBITDA between $13.5-14.5M
Last Updated: 17/11/2025, 22:42
Read Full Transcript

Compare LFMD to Peers and Sector

Metrics to compare
LFMD
Peers
Sector
Relationship
P/E Ratio
−15.0x−0.2x−0.6x
PEG Ratio
−0.240.040.00
Price/Book
127.1x1.2x2.6x
Price / LTM Sales
0.7x1.3x3.2x
Upside (Analyst Target)
165.6%56.0%41.8%
Fair Value Upside
Unlock36.0%5.1%Unlock

Analyst Ratings

7 Buy
1 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 9.25
(+167.34% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Freedom Capital Markets
Buy8.00+131.21%11.00Maintain24/11/2025
H.C. Wainwright
Buy9.00+160.12%13.00Maintain20/11/2025
KeyBanc
Buy8.00+131.21%12.00Maintain19/11/2025
Mizuho
Hold6.00+73.41%8.00Maintain19/11/2025
Lake Street Capital Markets
Buy8.00+131.21%14.00Maintain18/11/2025

Earnings

Latest Release
Nov 17, 2025
EPS / Forecast
-0.10 / -0.04
Revenue / Forecast
60.20M / 62.13M
EPS Revisions
Last 90 days

LifeMD (LFMD) Income Statement & Profits

People Also Watch

27.67
OLMA
-1.81%
3.690
PRME
-0.27%
1.130
HUMA
+5.61%
6.64
QTRX
-2.35%
3.0400
TPST
-2.56%

FAQ

What Is the LifeMD (LFMD) Share Price Today?

The live LifeMD share price today is 3.46

What Stock Exchange Does LifeMD (LFMD) Trade On?

LifeMD is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for LifeMD?

The stock symbol (also called a 'ticker') for LifeMD is "LFMD."

What Is the Current LifeMD Market Cap?

As of today, LifeMD market capitalisation is 166.55M.

What Is LifeMD's (LFMD) Earnings Per Share (TTM)?

The LifeMD EPS is currently -0.25 (Trailing Twelve Months).

When Is the Next LifeMD Earnings Date?

LifeMD's next earnings report will be released on 16 Mar 2026.

Is LFMD a Buy or Sell From a Technical Analyst Perspective?

Based on today's LifeMD moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has LifeMD Stock Split?

LifeMD has split 1 times. (See the LFMD stock split history page for full effective split date and price information.)

How Many Employees Does LifeMD Have?

LifeMD has 306 employees.

What is the current trading status of LifeMD (LFMD)?

As of 24 Dec 2025, LifeMD (LFMD) is trading at a price of 3.46, with a previous close of 3.20. The stock has fluctuated within a day range of 3.18 to 3.54, while its 52-week range spans from 3.18 to 15.84.

What Is LifeMD (LFMD) Price Target According to Analysts?

The average 12-month price target for LifeMD is USD9.25, with a high estimate of USD15 and a low estimate of USD6. 7 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +167.34% Upside potential.

What Is the LFMD Premarket Price?

LFMD's last pre-market stock price is 3.22. The pre-market share volume is 12,160.00, and the stock has decreased by 0.02, or 0.62%.

What Is the LFMD After Hours Price?

LFMD's last after hours stock price is 3.33, the stock has decreased by -0.13, or -3.76%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.